Technical Analysis for OTLC - Oncotelic Therapeutics, Inc

Grade Last Price % Change Price Change
D 0.261 -0.38% -0.0010
OTLC closed down 0.38 percent on Friday, June 11, 2021, on 63 percent of normal volume. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Down Down
Historical OTLC trend table...

Date Alert Name Type % Chg
Shooting Star Candlestick Bearish 0.00%
Doji - Bearish? Reversal 0.00%
Stochastic Reached Oversold Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Doji - Bullish? Reversal -0.38%
Outside Day Range Expansion -6.79%
Narrow Range Bar Range Contraction -3.33%
NR7 Range Contraction -3.33%
Lower Bollinger Band Walk Weakness -3.33%
Inside Day Range Contraction -3.33%
Older End-of-Day Signals for OTLC ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
No Alerts Yet. Alerts will only show here if at least one person is tracking alerts on this stock.
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Mateon Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing drugs for the treatment of orphan oncology indications. The company's lead product candidate is OT-101, an antisense against TGF-beta, which is in phase 3 clinical trials for pancreatic cancer and glioblastoma, as well as develops OT-101 for the treatment of various viruses, including severe acute respiratory syndrome and coronavirus. It also develops OXi4503 for the treatment of acute myeloid leukemia and myelodysplastic syndromes; and CA4P for the treatment of advanced metastatic melanoma. The company is headquartered in Agoura Hills, California.

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Cancer Clinical Medicine Drugs Biopharmaceutical Glioblastoma Antineoplastic Drugs Pancreatic Cancer Acute Myeloid Leukemia Bemcentinib Protein Kinase Inhibitors Treatment Of Acute Myeloid Leukemia

Is OTLC a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 0.345
52 Week Low 0.24
Average Volume 201,790
200-Day Moving Average 0.0000
50-Day Moving Average 0.2877
20-Day Moving Average 0.2852
10-Day Moving Average 0.2706
Average True Range 0.0299
ADX 11.99
+DI 8.9538
-DI 9.1693
Chandelier Exit (Long, 3 ATRs) 0.2478
Chandelier Exit (Short, 3 ATRs) 0.3447
Upper Bollinger Bands 0.3186
Lower Bollinger Band 0.2518
Percent B (%b) 0.14
BandWidth 23.4222
MACD Line -0.0076
MACD Signal Line -0.0050
MACD Histogram -0.0027
Fundamentals Value
Market Cap 23.82 Million
Num Shares 91.3 Million
Price-to-Sales 15.44
Price-to-Book 2.37
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.2970
Resistance 3 (R3) 0.2993 0.2897 0.2910
Resistance 2 (R2) 0.2897 0.2805 0.2885 0.2890
Resistance 1 (R1) 0.2753 0.2748 0.2730 0.2730 0.2870
Pivot Point 0.2657 0.2657 0.2645 0.2645 0.2657
Support 1 (S1) 0.2513 0.2565 0.2490 0.2490 0.2350
Support 2 (S2) 0.2417 0.2508 0.2405 0.2330
Support 3 (S3) 0.2273 0.2417 0.2310
Support 4 (S4) 0.2250